{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T22:10:26Z","timestamp":1784239826971,"version":"3.55.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T00:00:00Z","timestamp":1540252800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1007\/s00520-018-4501-x","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T08:40:22Z","timestamp":1540284022000},"page":"383-394","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":86,"title":["Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review"],"prefix":"10.1007","volume":"27","author":[{"name":"for the MASCC Bone Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ourania","family":"Nicolatou-Galitis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Kouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erofili","family":"Papadopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Vardas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Galiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel B.","family":"Epstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Elad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Campisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Tsoukalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kivanc","family":"Bektas-Kayhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Body","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cesar","family":"Migliorati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh V.","family":"Lalla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,23]]},"reference":[{"key":"4501_CR1","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O\u2019Ryan F (2014) American Association of Oral Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"4501_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s00520-015-2904-5","volume":"24","author":"AT Stopek","year":"2016","unstructured":"Stopek AT, FizaZi K, Body JJ, Brown JE, Carducci M, Diel I et al (2016) Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Support Care Cancer 24:447\u2013455","journal-title":"Support Care Cancer"},{"key":"4501_CR3","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1007\/s00520-017-4003-2","volume":"26","author":"M Schiodt","year":"2018","unstructured":"Schiodt M, Vadhan-Raj S, Chambers MC, Nicolatou-Galitis O, Politis C, Coropciuc R, Fedele S, Jandial D, Zhang J et al (2018) A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Support Care Cancer 26:1905\u20131915","journal-title":"Support Care Cancer"},{"key":"4501_CR4","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1007\/s00520-017-3903-5","volume":"26","author":"T Cann Van","year":"2018","unstructured":"Van Cann T, Loyson T, Verbiest A, Clement OM, Bechter O, Willems L et al (2018) Incidence of medication-related osteonecrosis of the jaw in patients treated with bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Support Care Cancer 26:869\u2013878","journal-title":"Support Care Cancer"},{"key":"4501_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/odi.12632","volume":"23","author":"PPL Fung","year":"2017","unstructured":"Fung PPL, Bedogni G, Bedogni A, Petrie A, Porter S, Campisi G, Bagan J, Fusco V, Saia G, Acham S, Musto P, Petrucci MT, Diz P, Colella G, Mignogna MD, Pentenero M, Arduino P, Lodi G, Maiorana C, Manfredi M, Hallberg P, Wadelius M, Takaoka K, Leung YY, Bonacina R, Schi\u00f8dt M, Lakatos P, Taylor T, de Riu G, Favini G, Rogers SN, Pirmohamed M, Nicoletti P, GENVABO Consortium, Fedele S (2017) Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicenter retrospective cohort study. Oral Dis 23:477\u2013483","journal-title":"Oral Dis"},{"key":"4501_CR6","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1097\/MD.0000000000000671","volume":"94","author":"KN Pilanci","year":"2015","unstructured":"Pilanci KN, Alco G, Ordu C, Sarsenov D, Celebi F, Erdogan Z, Agacayak F, Ilgun S, Tecimer C, Demir G, Erlp Y, Okkan S, Ozmen V (2015) Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment? Medicine 94:e671. \n                    https:\/\/doi.org\/10.1097\/MD.0000000000000671","journal-title":"Medicine"},{"key":"4501_CR7","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1111\/jcpe.12455","volume":"42","author":"E Gaudin","year":"2015","unstructured":"Gaudin E, Seidel L, Bacevic M, Rompen E, Lambert F (2015) Occurrence and risk indicators of medication-related osteonecrosis of the jaw after dental extraction: a systematic review and meta-analysis. J Clin Periodontol 42:922\u2013932","journal-title":"J Clin Periodontol"},{"key":"4501_CR8","doi-asserted-by":"publisher","unstructured":"McGowan K, McGowan T, Ivanovski S (2017). Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 1-10. doi:\n                    https:\/\/doi.org\/10.1111\/odi.12708","DOI":"10.1111\/odi.12708"},{"key":"4501_CR9","doi-asserted-by":"publisher","unstructured":"Pimolbutr K, Porter S, Fedele S (2018). Osteonecrosis of the jaw associated with antiangiogenics in antiresorptive-na\u00efve patient: a comprehensive review of the literature BioMed Res Int Article ID 8071579, doi: \n                    https:\/\/doi.org\/10.1155\/2018\/8071579","DOI":"10.1155\/2018\/8071579"},{"issue":"7","key":"4501_CR10","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1080\/14740338.2016.1177021","volume":"15","author":"V Fusco","year":"2016","unstructured":"Fusco V, Santini D, Armento G, Tonini G, Campisi G (2016) Osteonecrosis of the jaw beyond antiresorptive (bone-targeted) agents: new horizons in oncology. Expert Opin Drug Saf 15(7):925\u2013935","journal-title":"Expert Opin Drug Saf"},{"key":"4501_CR11","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Papadopoulou E, Sarri T, Boziari P, Karayanni A, Kyrtsonis MC. Repousis P, Barbounis V, Migliorati C (2011). Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center. Oral Surg Oral Med Oral Pathol Oral Radiol 112:195\u2013202","DOI":"10.1016\/j.tripleo.2011.02.037"},{"key":"4501_CR12","first-page":"26","volume":"1","author":"E Vardas","year":"2014","unstructured":"Vardas E, Coward T, Papadopoulou E, Nicolatou-Galitis O (2014) Dental extractions as the major local risk factor of bisphosphonates related jaw osteonecrosis in cancer therapy. A systematic review. Mediterranean Oncol J-MOJ 1:26\u201333","journal-title":"Mediterranean Oncol J-MOJ"},{"key":"4501_CR13","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","volume":"123","author":"S Fedele","year":"2010","unstructured":"Fedele S, Porter SR, D\u2019Aiuto F, Aljohani S, Vesconi P, Mafredi M, Arduino PG, Broccoletti R, Musciotto A, Di Fede O, Lazarovici TS, Campisi G (2010) Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: a case series. Am J Med 123:1060\u20131064","journal-title":"Am J Med"},{"key":"4501_CR14","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","volume":"18","author":"A Bedogni","year":"2012","unstructured":"Bedogni A, Fusco V, Agrillo A, Campisi G (2012) Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Oral Dis 18:621\u2013623","journal-title":"Oral Dis"},{"key":"4501_CR15","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","volume":"117","author":"M Schiodt","year":"2014","unstructured":"Schiodt M, Reibel J, Oturai P, Kofod T (2014) Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: a retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system. Oral Surg Oral Med Oral Pathol Oral Radiol 117:204\u2013213","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR16","unstructured":"Papadopoulou E, Nicolatou-Galitis O, Razis E, et al (2017). Localized alveolar bone disease prior to dental extraction in cancer patients treated with antiresorptives: an early stage of osteonecrosis of the jaw (ONJ)? [oral presentation]. Presented at the Multinational Association of Supportive Care in Cancer congress, 22\u201324 June 2017. Washington DC, USA 2017"},{"key":"4501_CR17","first-page":"c85","volume":"78","author":"M Troeltzsch","year":"2012","unstructured":"Troeltzsch M, Woodlock T, Kriegelstein S, Steiner T, Messlinger K, Mar T (2012) Physiology and pharmacology of nonbisphopshonate drugs implicated in osteonecrosis of the jaw. J Can Dent Assoc 78:c85","journal-title":"J Can Dent Assoc"},{"key":"4501_CR18","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s00520-012-1592-7","volume":"21","author":"JM Bowen","year":"2013","unstructured":"Bowen JM, Elad S, Hutchins RD, Lalla RV (2013) Methodology for the MASCC\/ISOO mucositis clinical practice guideline update. Support Care Cancer 21:303\u2013308","journal-title":"Support Care Cancer"},{"key":"4501_CR19","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/0895-4356(96)00019-4","volume":"49","author":"DC Hadorn","year":"1996","unstructured":"Hadorn DC, Baker D, Hodges JS, Hicks N (1996) Rating the quality of evidence for clinical practice guidelines. J Clin Epidemiol 49:749\u2013754","journal-title":"J Clin Epidemiol"},{"key":"4501_CR20","first-page":"881","volume":"4","author":"MR Somerfield","year":"2000","unstructured":"Somerfield MR, Padberg JJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guiedlines: process, progress, pitfalls, and prospects. Classic Pap Curr Comments 4:881\u2013886","journal-title":"Classic Pap Curr Comments"},{"key":"4501_CR21","doi-asserted-by":"publisher","first-page":"e100","DOI":"10.1016\/j.oraloncology.2015.08.014","volume":"51","author":"AA Owosho","year":"2015","unstructured":"Owosho AA, Scordo M, Yom SK, Randazzo J, Chapman PB, Huryn JM, Estilo CL (2015) Osteonecrosis of the jaw a new complication related to ipilimumab. Oral Oncol 51:e100\u2013e101. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2015.08.014","journal-title":"Oral Oncol"},{"key":"4501_CR22","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.oooo.2017.10.010","volume":"125","author":"HA Mahedi Mohamed","year":"2018","unstructured":"Mahedi Mohamed HA, Nor Nielsen CE, Schiodt M (2018) Medication related osteonecrosis of the jaws associated with targeted therapy as monotherapy and in combination with anti-resorptives. A report of seven cases from the Copenhagen ONJ cohort. Oral Surg Oral Med Oral Pathol Oral Radiol 125:157\u2013163. \n                    https:\/\/doi.org\/10.1016\/j.oooo.2017.10.010","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR23","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.joms.2016.07.019","volume":"75","author":"TL Aghaloo","year":"2017","unstructured":"Aghaloo TL, Tetradis S (2017) Osteonecrosis of the jaw in the absence of antiresorptive or antiangiogenic exposure: a series of 6 cases. J Oral Maxillofac Surg 75:129\u2013142","journal-title":"J Oral Maxillofac Surg"},{"key":"4501_CR24","doi-asserted-by":"publisher","unstructured":"Omarini C, Filieri ME, Depenni R, Grizzi G, Cascinu S, Piacentini F (2017). Osteonecrosis of the jaw in a breast cancer patient treated with everolimus and a single dose of zoledronic acid. The Breast J 1\u20132. doi: \n                    https:\/\/doi.org\/10.1111\/tbj.12808","DOI":"10.1111\/tbj.12808"},{"key":"4501_CR25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5125\/jkaoms.2017.43.2.120","volume":"43","author":"M Viviano","year":"2017","unstructured":"Viviano M, Rossi M, Cocca S (2017) A rare case of osteonecrosis of the jaw related to imatinib. J Korean Assoc Oral Maxillofac Surg 43:120\u2013124. \n                    https:\/\/doi.org\/10.5125\/jkaoms.2017.43.2.120","journal-title":"J Korean Assoc Oral Maxillofac Surg"},{"key":"4501_CR26","doi-asserted-by":"publisher","unstructured":"Erovigni F, Gambino A, Cabras M, Fasciolo A, Bianchi SD, Bellini E, Fusco V (2016) Delayed diagnosis of osteonecrosis of the jaw (ONJ) associated with bevacizumab therapy in colorectal cancer patients: report of two cases. Dent J 4:39. \n                    https:\/\/doi.org\/10.3390\/dj4040039","DOI":"10.3390\/dj4040039"},{"key":"4501_CR27","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3892\/mco.2016.1100","volume":"6","author":"D Yamamoto","year":"2017","unstructured":"Yamamoto D, Tsubota Y, Utsunomiya T, Sueoka N, Ueda A, Endo K, Yoshikawa K, Kon M (2017) Osteonecrosis of the jaw associated with everolimus: a case report. Mol Clin Oncol 6:255\u2013257. \n                    https:\/\/doi.org\/10.3892\/mco.2016.1100","journal-title":"Mol Clin Oncol"},{"key":"4501_CR28","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.bjoms.2016.11.315","volume":"55","author":"P Zarringhalam","year":"2017","unstructured":"Zarringhalam P, Brizman E, Shakib K (2017) Medication-related osteonecrosis of the jaw associated with aflibercept. Br J Oral Maxillofac Surg 55:314\u2013315. \n                    https:\/\/doi.org\/10.1016\/j.bjoms.2016.11.315","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4501_CR29","doi-asserted-by":"publisher","first-page":"e257","DOI":"10.1016\/j.oooo.2017.08.003","volume":"124","author":"V Patel","year":"2017","unstructured":"Patel V, Sproat C, Kwok J, Tanna N (2017) Axitinib-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 124:e257\u2013e260","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR30","doi-asserted-by":"publisher","unstructured":"Antonuzzo L, Lunghi A, Giommoni E, Brugia M, Di Costanzo F (2016) Regorafenib also can cause osteonecrosis of the jaw. J Natl Cancer Inst 108:djw002. \n                    https:\/\/doi.org\/10.1093\/jnci\/djw002","DOI":"10.1093\/jnci\/djw002"},{"key":"4501_CR31","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.joms.2015.07.019","volume":"74","author":"CR DeSeza","year":"2016","unstructured":"DeSeza CR, Appugoumder S, Haberland C, Johnson MP (2016) Osteonecrosis of the jaw in association with cutaneous T-cell lymphoma. J Oral Maxillofac Surg 74:292\u2013301","journal-title":"J Oral Maxillofac Surg"},{"issue":"Suppl 2","key":"4501_CR32","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.5301\/tj.5000504","volume":"102","author":"F Garuti","year":"2016","unstructured":"Garuti F, Camelli V, Spinardi L, Bucci L, Trevisani F (2016) Osteonecrosis of the jaw during sorafenib therapy for hepatocellular carcinoma. Tumori 102(Suppl 2):S69\u2013S70. \n                    https:\/\/doi.org\/10.5301\/tj.5000504","journal-title":"Tumori"},{"key":"4501_CR33","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.21037\/jgo.2016.05.07","volume":"7","author":"H Mawardi","year":"2016","unstructured":"Mawardi H, Enzinger P, McCleary N, Manon R, Villa A, Treister N, Woo S-B (2016) Osteonecrosis of the jaw associated with ziv-aflibercept. J Gastrointest Oncol 7:e81\u2013e87. \n                    https:\/\/doi.org\/10.21037\/jgo.2016.05.07","journal-title":"J Gastrointest Oncol"},{"key":"4501_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s00238-015-1112-3","volume":"39","author":"C Melloni","year":"2016","unstructured":"Melloni C, Tuttolomondo A, Anfosso A, Calamia C, Clemente FD, Cordova A (2016) Sunitinib related osteonecrosis of the jaw (SURONJ): a rare occurrence? Eur J Plast Surg 39:161\u2013162","journal-title":"Eur J Plast Surg"},{"key":"4501_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.20517\/2394-4722.2016.06","volume":"2","author":"O Nicolatou-Galitis","year":"2016","unstructured":"Nicolatou-Galitis O, Galiti D, Moschogianni M, Sachanas S, Edwards BJ, Migliorati CA, Pangalis G (2016) Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidine. J Cancer Metasta Treat 2:220\u2013223","journal-title":"J Cancer Metasta Treat"},{"issue":"Suppl 2","key":"4501_CR36","doi-asserted-by":"publisher","first-page":"S74","DOI":"10.5301\/tj.5000405","volume":"102","author":"A Ponzetti","year":"2016","unstructured":"Ponzetti A, Pinta F, Spadi R, Mecca C, Fanchini L, Zanini M, Ciuffreda L, Racca P (2016) Jaw osteonecrosis associated with aflibercept, irinotecan and fluorouracil: attention to oral district. Tumori 102(Suppl 2):S74\u2013S77. \n                    https:\/\/doi.org\/10.5301\/tj.5000405","journal-title":"Tumori"},{"key":"4501_CR37","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1111\/adj.12254","volume":"60","author":"R Marino","year":"2015","unstructured":"Marino R, Orlandi F, Arecco F, Gandolfo S, Pentenero M (2015) Osteonecrosis of the jaw in a patient receiving cabozantinib. Austr Dental J 60:528\u2013531. \n                    https:\/\/doi.org\/10.1111\/adj.12254","journal-title":"Austr Dental J"},{"key":"4501_CR38","doi-asserted-by":"publisher","first-page":"e302","DOI":"10.1016\/j.bjoms.2013.09.008","volume":"51","author":"DW Kim","year":"2013","unstructured":"Kim DW, Jung Y-S, Park H-S, Jung H-D (2013) Osteonecrosis of the jaw related to everolimus: a case report. Br J Oral Maxillofac Surg 51:e302\u2013e304. \n                    https:\/\/doi.org\/10.1016\/j.bjoms.2013.09.008","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4501_CR39","first-page":"29","volume":"4","author":"O Nicolatou-Galitis","year":"2013","unstructured":"Nicolatou-Galitis O, Razis E, Galiti D, Vardas E, Tzerbos F, Labropoulos S (2013) Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib - a case report with clinical implications. Forum Clin Oncol 4:29\u201333","journal-title":"Forum Clin Oncol"},{"key":"4501_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s10006-012-0379-9","volume":"17","author":"D Pakosch","year":"2013","unstructured":"Pakosch D, Papadimas D, Munding J, Kawa D, Kriwalsky MS (2013) Osteonecrosis of the mandible due to anti-angiogenic agent, bevacizumab. Oral Maxillofac Surg 17:303\u2013306. \n                    https:\/\/doi.org\/10.1007\/s10006-012-0379-9","journal-title":"Oral Maxillofac Surg"},{"key":"4501_CR41","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","volume":"115","author":"AR Santos-Silva","year":"2013","unstructured":"Santos-Silva AR, Rosa GAB, de Castro JG, Dias RB, Ribeiro ACP, Brand\u00e3o TB (2013) Osteonecrosis of the mandible associated with bevacizumab therapy. Oral Surg Oral Med Oral Pathol Oral Radiol 115:e32\u2013e36","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR42","doi-asserted-by":"publisher","first-page":"bcr2012007284","DOI":"10.1136\/bcr-2012-007284","volume":"2012","author":"G Bettini","year":"2012","unstructured":"Bettini G, Blandamura S, Saia G, Bedogni A (2012) Bevacizumab-related osteonecrosis of the mandible is a self-limiting disease process. BMJ Case Rep 2012:bcr2012007284. \n                    https:\/\/doi.org\/10.1136\/bcr-2012-007284","journal-title":"BMJ Case Rep"},{"key":"4501_CR43","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/039463201202500328","volume":"25","author":"P Brunamonti Binello","year":"2012","unstructured":"Brunamonti Binello P, Bandelloni R, Labanca M, Buffoli B, Rezzani R, Rodella LF (2012) Osteonecrosis of the jaws and bevacizumab therapy: a case report. Int J Immunopathol Pharmacol 25:789\u2013791","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4501_CR44","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/j.oraloncology.2011.07.030","volume":"48","author":"U Disel","year":"2012","unstructured":"Disel U (2012) A case report of bevacizumab-related osteonecrosis of the jaw: old problem, new culprit. Oral Oncol 48:e2\u2013e3. \n                    https:\/\/doi.org\/10.1016\/j.oraloncology.2011.07.030","journal-title":"Oral Oncol"},{"key":"4501_CR45","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.tripleo.2011.06.023","volume":"113","author":"Y Fleissig","year":"2012","unstructured":"Fleissig Y, Regev E, Lehman H (2012) Sunitinib related osteonecrosis of jaw: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol 113:e1\u2013e3","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR46","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.joms.2011.08.011","volume":"70","author":"P Infante-Cossio","year":"2012","unstructured":"Infante-Cossio P, Lopez-Martin JC, Gonzelez-Gardero E, Martinez-de-Fuentes R, Casas-Fernadez-Tejerina A (2012) Osteonecrosis of the maxilla associated with cancer chemotherapy in patients wearing dentures. J Oral Maxillofac Surg 70:1587\u20131592","journal-title":"J Oral Maxillofac Surg"},{"key":"4501_CR47","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.tripleo.2011.08.024","volume":"113","author":"O Nicolatou-Galitis","year":"2012","unstructured":"Nicolatou-Galitis O, Migkou M, Psyrri A, Bamias A, Pectasides D, Economopoulos T, Raber-Durlacher JE, Dimitriadis G, Dimopoulos MA (2012) Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications. Oral Surg Oral Med Oral Pathol Oral Radiol 113:234\u2013238. \n                    https:\/\/doi.org\/10.1016\/j.tripleo.2011.08.024","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR48","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10006-010-0224-y","volume":"15","author":"FP Koch","year":"2011","unstructured":"Koch FP, Walter C, Hansen T, J\u00e4ger E, Wagneret W (2011) Osteonecrosis of the jaw related to sunitinib. Oral Maxillofac Surg 15:63\u201366. \n                    https:\/\/doi.org\/10.1007\/s10006-010-0224-y","journal-title":"Oral Maxillofac Surg"},{"issue":"4","key":"4501_CR49","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1177\/039463200902200429","volume":"22","author":"E Serra","year":"2009","unstructured":"Serra E, Paolantonio M, Spoto G, Mastrangelo F, Tete S, Dolci M (2009) Bevacizumab-related osteneocrosis of the jaw. Int J Immunopathol Pharmacol 22(4):1121\u20131123","journal-title":"Int J Immunopathol Pharmacol"},{"key":"4501_CR50","doi-asserted-by":"publisher","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","volume":"26","author":"CL Estilo","year":"2008","unstructured":"Estilo CL, Fornier M, Farooki A, Carlson D, Bohle G III, Huryn JM (2008) Osteonecrosis of the jaw related to bevacizumab. JCO 26:4037\u20134038","journal-title":"JCO"},{"key":"4501_CR51","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1093\/annonc\/mdn653","volume":"19","author":"S Greuter","year":"2008","unstructured":"Greuter S, Schmid F, Ruhstaller T, Thuerlimann B (2008) Bevacizumab-associated osteonecrosis of the jaw. Ann Oncol 19:2091\u20132092","journal-title":"Ann Oncol"},{"key":"4501_CR52","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.oooo.2014.05.006","volume":"118","author":"F Hallmer","year":"2014","unstructured":"Hallmer F, Bjornland T, Nicklasson A, Becktor JP, Andersson G (2014) Osteonecrosis of the jaw in patients treated with oral and intravenous bisphosphonates: experience in Sweden. Oral Surg Oral Med Oral Pathol Oral Radiol 118:202\u2013208","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR53","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1111\/j.1600-0714.2011.01095.x","volume":"41","author":"G Fortuna","year":"2012","unstructured":"Fortuna G, Ruoppo E, Pollio A, Aria M, Adamo D, Leuci S, Dell\u2019Aversana Orabona G, Mignogna MD (2012) Multiple myeloma vs. breast cancer patients with bisphopshonates-related osteonecrosis of the jaws: a comparative analysis of response to treatment and predictors of outcome. J Oral Pathol Med 41:222\u2013228","journal-title":"J Oral Pathol Med"},{"key":"4501_CR54","doi-asserted-by":"publisher","unstructured":"Ramaglia L, Guida A, Iorio-Siciliano V, Cuozzo A, Blasi A, Sculean A (2018). Stage-specific therapies of medication-related osteonecrosis of the jaws: a systematic review and meta-analysis of the drug suspension protocol. Clin Oral Invest 597-615, doi: \n                    https:\/\/doi.org\/10.1007\/s00784-017-2325-6","DOI":"10.1007\/s00784-017-2325-6"},{"key":"4501_CR55","doi-asserted-by":"publisher","unstructured":"Hinson AM, Smith CW, Siegel ER, Stack BC Jr (2014). Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary. Internat J Dent article ID 452737, \n                    https:\/\/doi.org\/10.1155\/2014\/452737","DOI":"10.1155\/2014\/452737"},{"key":"4501_CR56","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.oooo.2015.08.007","volume":"120","author":"O Nicolatou-Galitis","year":"2015","unstructured":"Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A, Sgouros J, Karampeazis A, Migliorati C (2015) Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Oral Surg Oral Med Oral Pathol Oral Radiol 120:699\u2013706","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"4501_CR57","doi-asserted-by":"crossref","unstructured":"Otto S, Pautke C, Jurado OM< Nehrbass D, Stoddart MJ, Ehrenfeld M, Zeiter S (2017). Further development of the MRONJ minipig large animal model. J Cranio-maxillo-Facial Surg 45:1503\u20131514","DOI":"10.1016\/j.jcms.2017.07.002"},{"key":"4501_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.bjoms.2017.06.014","volume":"55","author":"RG Coropciuc","year":"2017","unstructured":"Coropciuc RG, Grisar K, Aerden T, Schol M, Schoenaers J, Politis C (2017) Medication-related osteonecrosis of the jaw in oncological patients with skeletal metastases: conservative treatment is effective up to stage 2. Br J Oral Maxillofac Surg 55:787\u2013792","journal-title":"Br J Oral Maxillofac Surg"},{"key":"4501_CR59","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J (1982) Toxicity and response criteria of the eastern cooperative oncology group. Am J Clin Oncol 5:649\u2013655","journal-title":"Am J Clin Oncol"},{"key":"4501_CR60","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1038\/sj.bdj.2017.79","volume":"222","author":"N Tanna","year":"2017","unstructured":"Tanna N, Steel C, Stagnell S, Bailey E (2017) Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners. Br Dental J 222:121\u2013125","journal-title":"Br Dental J"},{"key":"4501_CR61","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12903-016-0290-0","volume":"16","author":"JW Kim","year":"2016","unstructured":"Kim JW, Jeong SR, Kim SJ, Kim YS (2016) Perceptions of medical doctors on bisphosphonate-related osteonecrosis of the jaw. BMC Oral Health 16:92. \n                    https:\/\/doi.org\/10.1186\/s12903-016-0290-0","journal-title":"BMC Oral Health"},{"key":"4501_CR62","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1185\/03007995.2016.1170005","volume":"32","author":"A Taguchi","year":"2016","unstructured":"Taguchi A, Shiraki M, Sugimoto T, Ohta H, Soen S, Japan Osteoporosis S (2016) Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Curr Med Res Opin 32:1261\u20131268","journal-title":"Curr Med Res Opin"},{"key":"4501_CR63","doi-asserted-by":"crossref","unstructured":"Nicolatou-Galitis O, Migliorati C. (2018) Osteonecrosis of the jaw (ONJ) in patients who receive bone targeting agents (BTAs): the power of e-learning. ecancermedicalscience. 12","DOI":"10.3332\/ecancer.2018.ed77"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-018-4501-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-018-4501-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T12:07:37Z","timestamp":1571832457000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-018-4501-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,23]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["4501"],"URL":"https:\/\/doi.org\/10.1007\/s00520-018-4501-x","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,23]]},"assertion":[{"value":"10 May 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Ourania Nicolatou-Galitis and Cesar Migliorati have received consultant fee from AMGEN. Maria Kouri, Erofili Papadopoulou, Emmanouil Vardas, Dimitra Galiti, Joel Epstein, Sharon Elad, Giuseppina Campisi, Nikolaos Tsoukalas, Kivanc Bektas-Kayhan, Winston Tan, Jean-Jacques Body, and Rajesh Lalla declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}